Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single Institution-Reference-Cited by-同舟云学术

Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single Institution

Published:2013-11-08 Issue:11 Volume:8 Page:e78977
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Park Joo Kyung,Paik Woo Hyun,Ryu Ji Kon,Kim Yong-Tae,Kim Youn Joo,Kim Jaihwan,Song Byeong Jun,Park Jin Myung,Yoon Yong Bum

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Cancer statistics, 2012;R Siegel;CA Cancer J Clin,2012

2. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors;KC Conlon;Ann Surg,1996

3. Current therapies and advances in the treatment of pancreatic cancer;A Mancuso;Crit Rev Oncol Hematol,2006

4. Prognostic impact of postoperative serum CA 19–9 levels in patients with resectable pancreatic cancer;S Hata;Ann Surg Oncol,2012

5. The clinical utility of serum CA 19–9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal;UK Ballehaninna;J Gastrointest Oncol,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma;The American Journal of Surgery;2024-12

2. Highly sensitive and selective detection of the pancreatic cancer biomarker CA 19-9 with the electrolyte-gated MoS2-based field-effect transistor immunosensor;Ionics;2023-08-07

3. Highly sensitive and selective detection of the pancreatic cancer biomarker CA 19-9 with the electrolyte-gated MoS 2 -based field-effect transistor immunosensor;2022-09-23

4. The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer;Annals of Surgical Oncology;2022-09-19

5. Outcome Analysis of Patients Treated with Gemcitabine and Nab-Paclitaxelfor Unresectable Pancreatic Cancer;Journal of Nihon University Medical Association;2022-02-01